Pasithea Therapeutics Corp (KTTA) stock news · $5.6M cap
Pasithea Therapeutics Corp (KTTA) is a biotechnology company listed on US.
This KTTA news page leads with what Pasithea Therapeutics Corp filed — not a scraped headline mill.
No cached 8-K sentence for KTTA yet. We will not pad this page with generic market recap.
KTTA income-statement cache is thin, so the news desk waits on the next exhibit.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KTTA stock page; for the tape open the quote page.
Not investment advice.